Is your Order to Cash (OTC) process helping you maximize revenue—or quietly leaking it? In their latest article, EVERSANA experts Christina Christos and Jim Burke explore how pharmaceutical manufacturers can align OTC and Revenue Management to eliminate operational blind spots, reduce deductions and improve gross-to-net performance. It breaks down why real-time collaboration, a single source of truth and smarter reporting are no longer “nice to have”—they’re essential to staying competitive in today’s complex market.
What’s the hidden cost of a disconnected OTC and Revenue Management strategy?
-
Delayed revenue recognition
-
Increased manual effort and audit exposure
-
Strained relationships with wholesalers and customers
-
Inaccurate reserves and financial forecasting
When these functions operate in silos, your bottom line pays the price.
Author
Christina leads the order management team, accounts receivable, and the contact center operations. With over 20 years of experience, she brings a strong track record of driving operational excellence, optimizing revenue cycle processes, and…
Jim Burke leads the Revenue Management team with more than 20 years of experience optimizing gross-to-net operations for the pharmaceutical and medical device industries. An established thought leader in life sciences, he drives the implementation of best practices and innovative solutions that help…